Establishment Labs Holdings Equity 2024

Establishment Labs Holdings Aktienanalyse

What does Establishment Labs Holdings do?

Establishment Labs Holdings Inc. is a leading medical device manufacturer based in Costa Rica. The company was founded in 2004 by Juan José Chacón and Salvador Dada and has experienced strong growth since then. It is listed on the NASDAQ under the ticker ESTA since 2018. The company focuses on the development and manufacture of products that help women improve their beauty and health. Some of the most commonly offered products by Establishment Labs include breast implants, botulinum toxin injections, and hyaluronic acid fillers. These products are used by doctors and plastic surgeons worldwide. Establishment Labs' business model is based on the development of innovative products that adhere to the highest quality standards. The company invests heavily in research and development to ensure that its products are safe and effective. It also pursues a differentiated strategy to stand out from other providers. Most competitors have products that are based on leak-prone cohesive silicone gels or non-cohesive saline solutions. However, Establishment Labs has developed a patented technology based on ultra-cohesive silicone gels, which are supposed to be softer and have a lower leakage rate. The company is divided into two main segments: the breast implant market and the disposable injection market. In the breast implant market, Establishment Labs is a significant competitor to breast implant market leaders such as Allergan and Mentor. The company has also started entering the disposable injection market, focusing on the development of hyaluronic acid fillers. Establishment Labs' breast implants are manufactured under the name Motiva. Motiva implants are available in over 60 countries worldwide. They feature a variety of functions aimed at improving the health and comfort of patients. Some notable features include a nano-textured surface that allows for better integration; a circumferential self-sealing technology that offers higher resistance to ruptures and air inclusion and higher breaking recovery capacity; and a "TrueMonobloc" technology that enables implants made consistently from a single material, reducing the risk of contamination, capsular contracture, and ruptures. Establishment Labs has also recently introduced a custom 3D printer system that allows surgeons to customize the shape and size of breast implants for each patient. The disposable injection market is also a significant growth area for Establishment Labs. The company has recently acquired the license to sell Q-Med products in Mexico and is currently developing its own hyaluronic acid-based filler. The company also plans to enter the market for botulinum toxin injections in the future. Overall, Establishment Labs is an emerging medical technology company that focuses on the development of high-quality products for aesthetic surgery. The company has a strong research and development department and a differentiated strategy that allows it to stand out from the competition and establish a strong presence in a growing market. Establishment Labs Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Establishment Labs Holdings's Equity

Establishment Labs Holdings's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Establishment Labs Holdings's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Establishment Labs Holdings's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Establishment Labs Holdings's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Establishment Labs Holdings’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Establishment Labs Holdings stock

What is the equity of Establishment Labs Holdings this year?

Establishment Labs Holdings has equity of 18.4 M USD this year.

What was the equity of Establishment Labs Holdings compared to the previous year?

The equity of Establishment Labs Holdings has increased/decreased by -324.33% decreased compared to the previous year.

What impact does a high equity have on investors of Establishment Labs Holdings?

A high equity is advantageous for investors of Establishment Labs Holdings as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Establishment Labs Holdings?

A low equity can be a risk for investors of Establishment Labs Holdings, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Establishment Labs Holdings affect the company?

An increase in equity of Establishment Labs Holdings can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Establishment Labs Holdings affect the company?

A reduction in equity of Establishment Labs Holdings can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Establishment Labs Holdings?

Some factors that can affect the equity of Establishment Labs Holdings include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Establishment Labs Holdings so important for investors?

The equity of Establishment Labs Holdings is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Establishment Labs Holdings take to change the equity?

To change equity, Establishment Labs Holdings can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Establishment Labs Holdings pay?

Over the past 12 months, Establishment Labs Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Establishment Labs Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Establishment Labs Holdings?

The current dividend yield of Establishment Labs Holdings is .

When does Establishment Labs Holdings pay dividends?

Establishment Labs Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Establishment Labs Holdings?

Establishment Labs Holdings paid dividends every year for the past 0 years.

What is the dividend of Establishment Labs Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Establishment Labs Holdings located?

Establishment Labs Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Establishment Labs Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Establishment Labs Holdings from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Establishment Labs Holdings pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Establishment Labs Holdings in the year 2023?

In the year 2023, Establishment Labs Holdings distributed 0 USD as dividends.

In which currency does Establishment Labs Holdings pay out the dividend?

The dividends of Establishment Labs Holdings are distributed in USD.